Battle of billionaires: Mukesh Ambani’s Reliance and Jeff Bezos’s Amazon set to conflict on e-pharma

Picture Supply : FILE


The following large battle of billionaires Mukesh Ambani and Jeff Bezos is about to be on the e-pharma entrance. In keeping with a report within the Dwell Mint, each the businesses wish to diversify into the e-pharma section. Amazon India launched ‘Amazon Pharmacy’ in Bengaluru final week and can conduct a pilot in different cities. Reliance Retail, by means of its SMART Level retailers, plans to scale up its grocery and pharmacy platforms. The report stated that Reliance Industries Ltd (RIL), by means of its biotechnology subsidiary, Reliance Life Sciences, is already within the means of organising pathology labs by means of native partnerships. 

“E-pharmacies is a big market and the retail section is a fragmented one. Nonetheless, the market is now ripe for consolidation; thus, massive retailers like Amazon and Reliance are eager on this market,” the CEO of an Indian e-pharmacy agency was quoted as saying. The CEO stated extra retailers are ready to affix the sector amid authorities deal with healthcare and schemes like Ayushman Bharat, and Nationwide Digital Well being Mission. 

Amazon Pharmacy will supply each over-the-counter and prescription-based medicine, primary well being gadgets and conventional Indian natural medicines, Amazon stated in an announcement. In it March quarter analyst presentation, RIL stated that retail will scale up quickly led by new commerce and pharmacy platform.


  • In a bid to increase to extra classes, Amazon launched an internet pharmacy in Bengaluru. Amazon stated its new service ‘Amazon Pharmacy’ began accepting orders for each over-the-counter and prescription-based medicines in Bengaluru.
  • Amazon Pharmacy can also be promoting conventional natural medicines and a few well being gadgets resembling glucose meters, nebulizers and handheld massagers. 
  • Again in 2018, Amazon acquired on-line pharmacy startup PillPack for practically $1 billion.


In keeping with a report in ET, Reliance is predicted to announce the acquisition of Chennai-based e-pharmacy startup Netmeds for an estimated $120 million. 

“Like what befell within the horizontal e-commerce area the place Flipkart and Amazon got here out as winners whereas others fell by the wayside the identical will happen within the on-line pharms area. Reliance’s entry will give a tough time to the opposite gamers,” an funding banker informed ET.

Newest Enterprise Information

Struggle in opposition to Coronavirus: Full protection

Read Also:  ICICI Financial institution closes QIP; garners Rs 15,000 crore from share sale

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button